Gene expression signatures modulated by epidermal growth factor receptor activation and their relationship to cetuximab resistance in head and neck squamous cell carcinoma

BACKGROUND: Aberrant activation of signaling pathways downstream of epidermal growth factor receptor (EGFR) has been hypothesized to be one of the mechanisms of cetuximab (a monoclonal antibody against EGFR) resistance in head and neck squamous cell carcinoma (HNSCC). To infer relevant and specific...

Descripción completa

Detalles Bibliográficos
Autores principales: Fertig, Elana J, Ren, Qing, Cheng, Haixia, Hatakeyama, Hiromitsu, Dicker, Adam P, Rodeck, Ulrich, Considine, Michael, Ochs, Michael F, Chung, Christine H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460736/
https://www.ncbi.nlm.nih.gov/pubmed/22549044
http://dx.doi.org/10.1186/1471-2164-13-160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460736/
https://www.ncbi.nlm.nih.gov/pubmed/22549044
http://dx.doi.org/10.1186/1471-2164-13-160

Ejemplares similares